(Q40726979)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

0 references

1 reference

V Novitsky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Chigwedere

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Gaolekwe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H Bussman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G Sebetso

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Marlink

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E J Yunis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

146-156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

HIV-1 nomenclature proposal.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

HIV vaccines: where we are and where we are going

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Invited anniversary review: HLA associated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Influence of HLA Alleles on the Rate of Progression of Vertically Transmitted HIV Infection in Children: Association of Several HLA-DR13 Alleles with Long-Term Survivorship and the Potential Association of HLA-A2301 with Rapid Progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Biological basis of the HLA-B8,DR3-associated progression of acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

HLA and other host factors in transfusion-acquired HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Nomenclature for factors of the HLA system, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

HLA disease association and protection in HIV infection among African Americans and Caucasians.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

HLA antigens associated with susceptibility/resistance to HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Recombinant bacillus Calmette-Guérin as a potential vector for preventive HIV type 1 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

DNA vaccines: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

1 reference

7 January 2021

Delivery systems and adjuvants for vaccination against HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2800%2900236-6

7 January 2021

10.1016/S0198-8859(00)00236-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11182225%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference